13F-HR filed by Propel Bio Management, LLC
Propel Bio Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 38 holding rows worth $158,658,759.
- Accession
- 0000898432-26-000369
- Filer
- CIK 1969764
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 38 entries on the cover page, a total value of $158,658,759 stated on the cover page (in dollars after the unit check, H1), rows summing to $158,658,759 with VALUE read as dollars as filed, 13F file number 028-23914. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSimplify Asset Management Inc.028-20937
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PLAINS GP HLDGS L P | 72651A207 | LTD PARTNR INT A | 1,272,360 | $30,180,379 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 3,786,425 | $11,368,992 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 841,272 | $9,354,403 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 979,698 | $9,159,490 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 147,828 | $6,022,011 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 1,329,899 | $6,007,982 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 314,543 | $5,587,368 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 644,421 | $5,585,588 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 4,118,321 | $5,081,571 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 131,364 | $4,135,129 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 742,049 | $4,117,846 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 210,163 | $4,087,734 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 724,678 | $3,994,612 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 1,012,790 | $3,886,475 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 896,701 | $3,830,724 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 380,420 | $3,581,151 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 122,223 | $3,279,243 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 382,375 | $3,226,116 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 341,779 | $3,100,127 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 710,988 | $2,950,600 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 215,825 | $2,788,943 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 223,802 | $2,647,064 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 282,418 | $2,640,798 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 2,344,779 | $2,620,262 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,420,550 | $2,413,387 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 921,457 | $2,037,786 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 1,115,000 | $1,996,750 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 295,771 | $1,721,024 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 104,772 | $1,713,022 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 149,279 | $1,495,776 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 329,296 | $1,412,680 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 43,798 | $1,307,370 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 55,664 | $1,279,715 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 85,791 | $1,251,074 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 730,606 | $1,234,724 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 146,369 | $949,818 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 209,493 | $553,909 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 10,145 | $57,116 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000898432-26-000369 | this filing | 2026-05-14 | acceptance time not in the bulk data set |